跳至主要内容
临床试验/NCT06494033
NCT06494033
招募中
不适用

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients: a Single Center Prospective Study

University of Miami1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年7月3日最近更新:
适应症Lung Diseases

概览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Positive CMV Immunoglobulin (IgG) positive lung transplant

概览

简要总结

The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients over 18 years of age
  • Lung transplant candidates with positive CMV IgG
  • Anticipated to receive a lung transplant (both double lung and single lung)

排除标准

  • Negative CMV IgG prior transplant
  • Pregnant or breastfeeding women
  • HIV infected patients
  • Combined organ (e.g., lung-heart, lung-kidney) transplant candidates

结局指标

主要结局

Positive CMV Immunoglobulin (IgG) positive lung transplant

时间窗: Up to 1 year

Positive CMV Immunoglobulin (IgG) measured by IU/ml

次要结局

  • Graft Outcome status(Up to 1 year)
  • Number of dead participants(Up to 1 year)
  • Duration of CMV medication(Up to 1 year)
  • Number of patients with CMV-positive results(Up to 1 year)
  • Severity of CMV Disease(Up to 1 year)
  • Severity of Torque Teno virus(Up to 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yoichiro Natori

Associate Professor of Clinical

University of Miami

研究点 (1)

Loading locations...

相似试验